Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lab Notes: Jazz agrees to multimillion-dollar drug sale; Lannett takes 'major step' with biosimilar By: Philadelphia Business Journal via Business Journals April 01, 2022 at 13:16 PM EDT Jazz has entered into a definitive agreement to sell the rights to one of its drugs in a deal that includes a $53 million upfront payment. Read More >> Related Stocks: Harbor Disruptive Innovation ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Lab Notes: Jazz agrees to multimillion-dollar drug sale; Lannett takes 'major step' with biosimilar By: Philadelphia Business Journal via Business Journals April 01, 2022 at 13:16 PM EDT Jazz has entered into a definitive agreement to sell the rights to one of its drugs in a deal that includes a $53 million upfront payment. Read More >> Related Stocks: Harbor Disruptive Innovation ETF